Rituximab, Intravitreal Bevacizumab and Laser Photocoagulation for Treatment of Macrophage Activation Syndrome and Retinal Vasculitis in Lupus: A Case Report

Systemic lupus erythematosus (SLE) most commonly manifests as mild to moderate disease with severe manifestations such as diffuse alveolar hemorrhage, central nervous system vasculitis, macrophage activation syndrome (MAS) or retinal vasculitis (RV) with visual disturbances occurring in a significan...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikić Matijašević, Marina, Kilić, Paula, Ikić, Lucija, Galić, Iva, Brzović Šarić, Vlatka, Galić, Edvard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916420/
https://www.ncbi.nlm.nih.gov/pubmed/36768956
http://dx.doi.org/10.3390/ijms24032594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916420/
https://www.ncbi.nlm.nih.gov/pubmed/36768956
http://dx.doi.org/10.3390/ijms24032594

Ejemplares similares